Press Page

DÜSSELDORF / TEL-AVIV September 13, 2022 – iuvo Therapeutics GmbH (“iuvo”) and Advanced Canna Technologies Ltd. (“ACT”) signed a non-binding letter of intent (LOI) concerning the supply of cannabis flowers. Key messages: iuvo and ACT signed a non-binding letter of intent.iuvo expands supplier network in preparation for recreational legalization in Germany.ACT produces premium-quality cannabis. The non-binding LOI expresses […]

Alexander Rieg took over the position of Daniel Seidl as Managing Director at iuvo Therapeutics at the turn of the year.

Potsdam/ Hanover, November 5, 2021 – In collaboration with Prof. Dr. Matthias Karst from the Hannover Medical School (MHH) iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is organizing a practice-relevant online training course for doctors on cannabis‑based medicine (CBM) on November 17, 2021. The advanced training course “Insights into an efficient therapy with cannabis-based pharmaceuticals”, […]

Düsseldorf / Frankfurt am Main, November 4, 2021 – iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is expanding its sales network: Cansativa GmbH (Cansativa) now offers iuvo’s high-quality full-spectrum cannabis extracts. iuvo Therapeutics and Cansativa have entered into a strategic distribution partnership. The well-established wholesaler with a focus on cannabis-based pharmaceuticals has expanded its product […]

Düsseldorf, October 2021 – iuvo Therapeutics GmbH is proud to announce Alexander Rieg has joined the management team as of October 2021. With his extensive experience in the sales and marketing of pharmaceuticals in Germany, Alexander Rieg founded and acted as managing director of GECA Pharma GmbH. One of the first fully licensed importers of […]